Human thymic stromal lymphopoietin (TSLP) is a novel epithelial cell-derived cytokine, which induces dendritic cell (DC)-mediated CD4 ϩ T cell responses with a proallergic phenotype. Although the participation of CD8 ϩ T cells in allergic inflammation is well documented, their functional properties as well as the pathways leading to their generation remain poorly understood. Here, we show that TSLP-activated CD11c ϩ DCs potently activate and expand naive CD8 ϩ T cells, and induce their differentiation into interleukin (IL)-5 and IL-13-producing effectors exhibiting poor cytolytic activity. Additional CD40L triggering of TSLP-activated DCs induced CD8 ϩ T cells with potent cytolytic activity, producing large amounts of interferon (IFN)-␥ , while retaining their capacity to produce IL-5 and IL-13. These data further support the role of TSLP as initial trigger of allergic T cell responses and suggest that CD40L-expressing cells may act in combination with TSLP to amplify and sustain pro-allergic responses and cause tissue damage by promoting the generation of IFN-␥ -producing cytotoxic effectors.
Introduction
Thymic stromal lymphopoietin (TSLP) is a novel IL-7-like cytokine, cloned from a murine thymic stromal cell line (1) . While mouse TSLP supports early B and T cell development, human TSLP (hTSLP) only activates CD11c ϩ dendritic cells (DCs), but not other antigen presenting cells, B, T, NK cells, neutrophils, nor mast cells (2, 3) . This is in accordance with the coexpression of mRNA for the IL-7R ␣ chain and TSLPR by CD11c ϩ DCs but not other cell types (2) . Unlike most DC activators such as CD40-ligand and ligands for Toll-like receptors (LPS, CPG-DNA, poly I:C), hTSLP does not induce DCs to produce proinflammatory cytokines (IL-1, IL-6, TNF-␣ , and IL-12), but TH2-attracting chemokines TARC and MDC (3) . Interestingly, hTSLP-activated DCs prime CD4 ϩ T helper cells to produce proallergic cytokines IL-4, IL-5, IL-13, and TNF-␣ , while down-regulating IL-10 and IFN-␥ . hTSLP is highly expressed by epithelial cells of inflamed tonsils and keratinocytes of atopic dermatitis and its expression is associated with Langerhans cell migration and activation (3) . hTSLP represents the first epithelial cell-derived cytokine that directly triggers DC-mediated TH2 allergic inflammation.
Allergic inflammation is the result of a complex immunological cascade involving the production of TH2 cytokines IL-4, IL-5, and IL-13, which leads to eosinophilia and IgE-production by B cells (4, 5) . The production of these proallergic TH2 cytokines was initially ascribed to CD4 ϩ T cells (6, 7) . There is now broader evidence that CD8 ϩ T cells, once regarded solely as potent cytotoxic effectors in antiviral and antitumoral immunity, are also able to secrete TH2 cytokines (8) (9) (10) . Substantial numbers of CD8 ϩ T cells participate in allergic inflammation (11, 12) . However, the functional properties of such CD8 ϩ T cells as well as the pathways leading to their generation remain poorly understood.
In this study we demonstrate that human TSLP primes DCs to induce naive CD8 ϩ T cell activation and differentiation into IL-5-and IL-13-producing T cells. Additional CD40 ligand stimulation of TSLP-DCs induced the differentiation of CD8 ϩ T cells into effectors that exhibit potent cytolytic activity and produce large amounts of IFN-␥ , in addition to IL-5 and IL-13, two types of cytokines that were considered to be mutually exclusive (13) .
Proallergic Cytotoxic CD8 ϩ T Cells Our data suggest that TSLP-activated DCs play an important role in inducing both CD4 ϩ and CD8 ϩ T cell-mediated allergic inflammation.
Materials and Methods
DC Purification and Culture. CD11c ϩ DCs were purified from buffy coats of HLA-A2-positive volunteer blood donors after separation of PBMCs by Ficoll-Hypaque centrifugation (Amersham Biosciences) and immunomagnetic depletion using mouse anti-CD3 (OKT3), anti-CD14 (RPA-M1), anti-CD19 (Leu-12), anti-CD56 (Leu-19), and anti-glycophorin-A (10F7MN) followed by magnetic beads coated with goat antimouse IgG (Dynabeads M-450; Dynal). Depleted cells were further stained with PE-Cy5-conjugated anti-CD4 (Caltag), PEconjugated anti-CD11c and FITC-conjugated anti-CD3, CD14, CD16, and CD20 (all Becton Dickinson). FITC Ϫ CD11c ϩ DCs were isolated with a Vantage FACsorter™ (Becton Dickinson) to reach a purity Ͼ 99% .
CD11c ϩ DCs were cultured immediately after sorting in RPMI containing 10% FCS, 1% pyruvate, 1% HEPES, and penicillin-streptomycin. Cells were seeded at 0.5 ϫ 10 6 /ml in flatbottomed 96-well plates in the presence of medium alone, TSLP (15 ng/ml), CD40L-transfected L fibroblasts (2.5 ϫ 10 4 /well), or a combination of TSLP and CD40L-transfected L fibroblasts. DCs were harvested after 24 h of culture and stained with FITClabeled anti-CD80 and anti-CD86 (Becton Dickinson) to assess their state of maturation.
Isolation of Naive CD8 ϩ T Lymphocytes from Adult Blood. Naive CD8 ϩ T cells were enriched from PBMCs of HLA-A2-negative healthy donors by immunomagnetic depletion using a cocktail of mouse anti-CD4, anti-CD14, anti-CD16, anti-CD19, anti-HLA-DR, and anti-CD45RO mAb, followed by magnetic beads coated with goat anti-mouse IgG. These cells were stained with PE-Cy5-conjugated anti-CD45RA, PE-conjugated anti-CD27 (both BD Biosciences), and a cocktail of FITC-conjugated anti-CD4, anti-␥␦ TCR, anti-CD14, anti-CD16, and anti-CD20 mAbs (Becton Dickinson). CD27 ϩ CD45RA ϩ lineage Ϫ cells were isolated by fluorescence activated cell sorting and were Ͼ 98% CD8 ϩ T cells. CD8 ϩ CD27 ϩ CD45RA ϩ have been previously described as naive CD8 ϩ T cells.
DC/CD8 T Cell Cocultures. CD11c ϩ DCs were collected after 24 h of culture under different conditions, washed twice to remove any residual cytokine, and cultured with 5 ϫ 10 4 freshly isolated naive CD8 ϩ T cells in round-bottomed 96-well plates at a ratio of 1:5 DC:T cell. After 6 d, cultures were harvested and numbers of viable cells determined by trypan blue exclusion.
Analysis of Cytokine Production. To test their capacity to secrete cytokines, harvested CD8 ϩ T cells (10 6 /ml) were restimulated with plate-bound anti-CD3 mAb (10 g/ml) plus 1 g/ml soluble anti-CD28 mAb for 24 h. IFN-␥ , TNF-␣ , IL-4, IL-5, IL-13, and IL-10 in the culture supernatants were measured by Quantikine ELISA kits (R&D Systems).
Cytotoxicity Assay and Intracellular Perforin Expression. Harvested CD8 ϩ T cells were tested for the capacity to lyse 51 Crlabeled HLA-A2-positive EBV-B lymphoblastoid cell line JY. The HLA-A2-negative EBV-LCL RSB cell line (DNAX) was used as negative control target. The assay was performed by incubating 2,500 51 Cr-labeled target cells per well with indicated numbers of effectors at 37 Њ C for 5 h before collecting the supernatants and measuring 51 Cr release with a gamma counter. We used Triton X to determine the maximum lysis, and target cells alone to determine the spontaneous lysis. The percentage lysis was calculated as follows: (spontaneous cpm Ϫ experimental cpm)/spontaneous cpm. For quantification of perforin expression by CD8 T cells, harvested cells were stained with PE-labeled anti-CD8, fixed with 2% formaldehyde (Sigma-Aldrich), and permeabilized with PBS supplemented with 2% FCS, 0.1% NaN3, and 0.5% saponin (Sigma-Aldrich). Cells were then stained with FITC-labeled anti-perforin mAb (for 20 min) and analyzed on a FACScan™ flow cytometer.
Results
TSLP-DCs Induce Strong CD8 ϩ T Cell Expansion. The capacity of DCs cultured with human TSLP (TSLP-DC) to activate and differentiate naive CD8 ϩ T cells was determined in comparison to DCs cultured either with medium alone, CD40L (CD40L-DC), or with a combination of TSLP and CD40L (CD40L ϩ TSLP-DC). Whereas DCs cultured with medium alone did not induce significant CD8 ϩ T cell expansion, CD40L-DCs induced a 1.4 to 2.8-fold expansion of CD8 ϩ T cells after 6 d of coculture (Fig. 1 A) . TSLP-DCs induced a 2.8 to 5.6-fold increase in CD8 ϩ T cell number, which was 2 times more than that induced by CD40L-DCs (Fig. 1 A) . CD40L and TSLP had a strong synergistic effect in activating DCs, as shown by the very high levels of CD80 and CD86 expression (Fig. 1  B) , and the ability to induce the strongest CD8 ϩ T cell expansion (4.5 to 8.2-fold). Thus, TSLP, either alone or in combination with CD40L, represents a very potent DC activation factor with a marked capacity to induce DC-mediated activation and expansion of naive CD8 ϩ T cells.
TSLP-DCs Prime CD8 ϩ T Cells to Produce Large Amounts of IL-5 and IL-13.
To determine the capacity of TSLPDCs to polarize naive CD8 ϩ T cells into cytokine-producing cells, DC-primed CD8 ϩ T cells were restimulated for 24 h with anti-CD3 and anti-CD28 and cytokine production was measured in the culture supernatant by ELISA (Fig. 2) . CD8 ϩ T cells primed with medium-DCs produced low levels of IFN-␥ and TNF-␣ , and did not produce detectable amounts of IL-4, IL-5, or IL-10. CD8 ϩ T cells primed with CD40L-DCs produced large amounts of IFN-␥ and TNF-␣ , low amounts of IL-5 and undetectable amounts of IL-13, IL-4, or IL-10. Interestingly, CD8 ϩ T cells primed by TSLP-DCs produced large amounts of IL-5 (up to 350 pg/ml) and IL-13 (up to 170 pg/ml), and moderate amounts of IFN-␥ and TNF-␣ , but did not produce detectable amounts of IL-4 and IL-10. DCs activated by TSLP together with CD40L primed CD8 ϩ T cells to produce the highest levels of IL-5, IL-13, TNF-␣ , and IFN-␥ , but undetectable amounts of IL-4 and IL-10.
TSLP-DC Activated in the Presence of CD40L Induce Highly Cytotoxic CD8 ϩ T Cells and Secrete IL-5, IL-13
, and IFN-␥ . Next, we asked whether these polarized effector CD8 ϩ T cells had characteristics of cytotoxic T cells and could kill allogeneic targets (Fig. 3 A) . DCs cultured for 24h in medium alone did not induce cytotoxic CD8 ϩ T cell activity (cytolytic activity was not significantly different from cytolytic activity against autologous targets). Low lev-Gilliet et al. Brief Definitive Report els of cytotoxic activity were detected in both CD8 ϩ T cells primed with CD40L-DC or TSLP-DCs (cytolytic activity detectable at the lowest ratio of 15 effector to 1 target cell). In contrast, CD40L-TSLP-DCs induced very potent of CD8 ϩ cytotoxic T cells, detectable at ratios as low as 1 effector to 1 target (Fig. 3 A) . The cytotoxic activity correlated with the intracellular perforin expression (Fig. 3 B) .
Discussion
In this study, we report that DCs activated by TSLP have a marked ability to expand naive CD8 ϩ T cells and induce their differentiation into IL-5 and IL-13 secreting CD8 ϩ T cells. Furthermore, we show that the addition of CD40L to the TSLP-mediated DC activation induced CD8 ϩ T cell differentiation into potent cytolytic effectors secreting high levels of IFN-␥ , while retaining their ability to produce high levels of IL-5 and IL-13.
The importance of CD8 ϩ T cells in the pathogenesis and exacerbation of allergic diseases has been recently highlighted by the identification of allergen-specific CD8 ϩ T cells (14) . In addition, large numbers of CD8 ϩ T cells secreting IL-5 and IL-13 have been observed in the inflammatory infiltrate of allergic asthma (15) and atopic dermatitis (12) as well as in the blood of patients with drug allergies (16) . CD8 ϩ T cell-derived IL-5 and IL-13 were shown to exert their proallergic functions by inducing eosinophilia and increased IgE production, both in-vitro and in-vivo (12, Proallergic Cytotoxic CD8 ϩ T Cells 17). Interestingly, IL-10, a cytokine also produced by Th2 clones, was shown to be decreased in allergic diseases (14, 18) , and can suppress allergic inflammation (19, 20) . In our study, CD8 ϩ T cells induced by TSLP-activated DCs produced high levels of IL-5 and IL-13, but low levels of IL-10, thus exhibiting a typical proallergic cytokine profile. This parallels our data on CD4 ϩ T cells, which can be instructed to produce high levels of proallergic cytokines but low levels of IL-10, when cultured with TSLP-activated DCs (3) .
Allergic inflammation typically develops in two phases with a switch from the initial type 2 cytokine profile in acute lesions to increasing levels of IFN-␥ and high numbers of cytolytic effectors in chronic lesions, while proallergic type 2 cytokines still remain at high levels (21) (22) (23) . In atopic dermatitis, both the increased IFN-␥ production as well as the presence of high numbers of cytotoxic T cells represent key pathogenic factors leading to epidermal injury and the formation of the eczematous lesion (24, 25) . In allergic asthma, CD8 ϩ T cell-derived IFN-␥ has been linked to bronchial hyperresponsiveness (26, 27) and the number of lesional cytotoxic CD8 ϩ T cells have been associated with the severity of the disease (28) . Our data suggest that TSLP may represent the initial trigger of allergic inflammation, by instructing DCs to induce IL-5 and IL-13 production by CD8 ϩ T cells. In a second step, CD40L triggering of TSLP-activated DCs could induce IFN-␥ production and high cytotoxicity by CD8 ϩ T cells, which would have characteristics of pathogenic T cells of the late phases of allergy. These IL-5, IL-13, and IFN-␥-producing cytolytic effectors might act to amplify and sustain the proallergic response, and to cause tissue damage. In this two-step process, an important question is the source of CD40L, in vivo. It is generally accepted that CD40L stimulation essentially comes from activated CD4 ϩ T cells within secondary lymphoid organs, during the DC-T cell cross-talk (29) . However, a number of CD40L-expressing cells are recruited to the site of allergic inflammation and could deliver a CD40 trigger to the TSLP-activated DCs, in situ. These include Ag-specific T helper cells, but also eosinophils and basophils, which express significant levels of CD40L (30) .
Our study provides further evidence that human TSLP might represent a key early mediator of allergic inflammation. The central role of TSLP, which acts upstream of both CD4 ϩ and CD8 ϩ proallergic T cell responses, should encourage clinical studies with specific TSLP inhibitors in allergic diseases.
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